Alerts will be sent to your verified email
Verify Email
RPGLIFE
|
RPG Life Sciences
|
Alembic
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceutical Sector
|
|||
|
Domestic Sales Growth - YoY
|
-11.18 % | 10.3 % | n/a |
|
R&D as a % of Total Sales
|
1.5 % | 0.06 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
20.08 % | 13.7 % | 41.95 % |
|
5yr average Equity Multiplier
|
1.4 | 1.05 | 1.37 |
|
5yr Average Asset Turnover Ratio
|
1.26 | 0.05 | 0.89 |
|
5yr Avg Net Profit Margin
|
11.59 % | 303.17 % | 34.6 % |
|
Price to Book
|
9.43 | 1.55 | 14.59 |
|
P/E
|
50.63 | 11.25 | 61.85 |
|
5yr Avg Cash Conversion Cycle
|
-64.92 Days | 79.64 Days | -31.8 Days |
|
Inventory Days
|
63.34 Days | 237.67 Days | 23.52 Days |
|
Days Receivable
|
25.32 Days | 50.07 Days | 48.29 Days |
|
Days Payable
|
145.09 Days | 292.14 Days | 135.34 Days |
|
5yr Average Interest Coverage Ratio
|
17.66 | 181.25 | 187.52 |
|
5yr Avg ROCE
|
27.52 % | 4.08 % | 54.74 % |
|
5yr Avg Operating Profit Margin
|
19.26 % | 20.81 % | 45.69 % |
|
5 yr average Debt to Equity
|
0.02 | 0.0 | 0.05 |
|
5yr CAGR Net Profit
|
24.75 % | -3.98 % | 20.11 % |
|
5yr Average Return on Assets
|
14.44 % | 13.04 % | 30.29 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.81 % | 70.88 % | 70.86 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 3.3 % |
|
Change in Promoter Holding (3 Yrs)
|
0.74 % | 0.0 | -4.13 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
2.67 % | -4.84 % | 1.14 % |
|
RPG Life Sciences
|
Alembic
|
Guj. Themis Biosyn
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|